Myotonic dystrophy is not the same as muscular dystrophy, but it is one specific type within the larger muscular dystrophy family. Think of muscular dystrophy as an umbrella term covering more than nine distinct genetic disorders that cause progressive muscle weakness. Myotonic dystrophy falls under that umbrella as the most common form of muscular dystrophy to begin in adulthood.
How the Two Terms Relate
Muscular dystrophy refers to a whole group of inherited conditions that share one core feature: muscles weaken and break down over time. The CDC lists at least nine major types, including Duchenne, Becker, limb-girdle, facioscapulohumeral, and myotonic dystrophy. Each type is caused by a different genetic mutation, affects different muscle groups, follows a different inheritance pattern, and progresses at a different rate. Saying someone has “muscular dystrophy” is a bit like saying they have “cancer.” It tells you the general category but not the specific disease.
Myotonic dystrophy (often abbreviated DM) is one entry on that list. It has its own genetic cause, its own set of symptoms, and a feature that sets it apart from every other muscular dystrophy: myotonia.
What Makes Myotonic Dystrophy Unique
Myotonia is a delayed relaxation of muscles after they contract. If you grip a doorknob, for example, your hand may stay clenched for several seconds before the muscles release. This inability to relax on command is the hallmark symptom and the reason “myotonic” is in the name. Other muscular dystrophies cause weakness and wasting, but they do not cause this kind of muscle stiffness.
Beyond myotonia, myotonic dystrophy stands out because it is a multisystem disorder. It doesn’t stop at muscles. It affects the eyes, heart, hormonal system, and brain. Cataracts develop in nearly all patients, typically appearing in their 40s. More than 50% of people with DM develop cardiac abnormalities, including dangerous rhythm disturbances that can show up even before noticeable muscle weakness. Insulin resistance raises the risk of diabetes, and men commonly experience low testosterone and infertility due to testicular changes. Women face higher rates of miscarriage and preterm birth.
This widespread organ involvement is unusual among muscular dystrophies. Duchenne muscular dystrophy, for comparison, primarily devastates skeletal muscles and eventually the heart, but it doesn’t typically cause cataracts, hormonal disruption, or the cognitive changes seen in DM.
Two Types of Myotonic Dystrophy
Myotonic dystrophy itself comes in two forms, each caused by a different gene mutation.
Type 1 (DM1) results from an abnormal expansion of a repeating DNA sequence in a gene called DMPK. Healthy copies of this gene have a small number of these repeats; in DM1, the sequence expands to anywhere from 50 to over 1,000 copies. The more repeats, generally the more severe the disease. DM1 can appear at any age, from birth through late adulthood, and is grouped into four forms: congenital, early childhood, adult-onset, and late-onset. The congenital form is the most severe, causing extreme weakness and intellectual disability from birth. In adult-onset DM1, weakness tends to hit the hands, forearms, lower legs, and face first, then gradually spreads. Facial and jaw weakness is always present, giving many people with DM1 a characteristic long, thin face.
Type 2 (DM2) is caused by a different repeat expansion in a gene called CNBP. It is generally less severe than DM1. There is no congenital form, and onset typically occurs between ages 8 and 60. The pattern of weakness is different too: DM2 primarily affects the muscles closer to the trunk, like the thighs and hips, rather than the hands and feet. Facial weakness is usually absent. Myotonia itself is less prominent, showing up in fewer than half of DM2 patients. One distinguishing feature is muscle pain, which affects at least 50% of people with DM2 but is uncommon in DM1.
Inheritance Compared to Other Types
The way myotonic dystrophy is passed down in families also differs from some of the better-known muscular dystrophies. DM1 and DM2 are both autosomal dominant, meaning you only need one copy of the faulty gene (from one parent) to develop the disease. Each child of an affected parent has a 50% chance of inheriting it.
Duchenne and Becker muscular dystrophies, by contrast, are X-linked. They overwhelmingly affect boys because the gene responsible sits on the X chromosome. Girls who carry one faulty copy usually have a working backup on their other X chromosome. This difference in inheritance pattern is one reason myotonic dystrophy affects men and women in roughly equal numbers, while Duchenne is almost exclusively a disease of young boys.
DM1 also has a feature called anticipation: the genetic repeat expansion tends to grow larger with each generation, so children often develop symptoms earlier and more severely than their parents did. This is unusual among muscular dystrophies and rarely occurs in DM2.
How It Is Diagnosed
If a doctor suspects myotonic dystrophy based on characteristic muscle weakness and grip myotonia, genetic testing confirms the diagnosis. A blood test looks for the expanded DNA repeat in either the DMPK gene (for DM1) or the CNBP gene (for DM2). This molecular test catches nearly 100% of cases. Electromyography, a test that records electrical activity in muscles using a needle electrode, can detect the distinctive pattern of myotonic discharges, but it has largely been replaced by genetic testing as the primary diagnostic tool.
Ongoing Monitoring and Management
Because myotonic dystrophy affects so many organ systems, managing it requires more than just tracking muscle strength. Cardiac monitoring is a major priority. Heart rhythm problems develop progressively and are the second leading cause of death in DM1, after respiratory failure. People with DM typically undergo regular heart rhythm recordings. Those with normal results may need monitoring less frequently, while those showing prolonged electrical intervals or reduced heart function may need yearly evaluations or more.
Screening for diabetes through fasting blood sugar and long-term glucose markers is recommended at diagnosis and annually. Thyroid function is also checked regularly. Men are screened for low testosterone. Eye exams track cataract development, and respiratory function is monitored because the breathing muscles progressively weaken over time.
Life Expectancy and Outlook
The prognosis varies dramatically depending on the type and severity. DM2 generally falls within a normal life expectancy range. DM1 is a different story. A long-term follow-up study found a median survival of about 55 years for DM1 patients, with more than half of deaths tied to respiratory failure from progressive muscle weakness. Cardiovascular disease was the second most common cause. Patients with the congenital form fared worse, with a median age at death around 45 years, and roughly 25% of congenitally affected infants dying within the first 18 months, primarily from breathing complications.
The late-onset, milder form of DM1 carries a much better outlook. People with this form may have little more than mild grip myotonia and cataracts developing after age 40, with relatively preserved muscle strength.